- –World market, 2023
- –Projected, 2033
- –Growth a year (CAGR)
- –Active clinical trials worldwide
Digital Diabetes Management by country and region
Australia
Brazil
Canada
China
Ecuador
Egypt
France
Germany
Hong Kong
India
Italy
Japan
Kenya
Malaysia
Mexico
New Zealand
Philippines
Russia
Saudi Arabia
Singapore
South Africa
Spain
Thailand
UAE
UK
US"–" means we have no size for that place yet. 2033 values are projected from the 2023 size and the CAGR. Regions count only the countries we report on for trials.
Latest research 8,798 papers since 2021
- Advances in the hospital management of hyperglycemia and type 2 diabetes in non-critical care settings. BMJ open diabetes research & care, 2026
- Continuous Glucose Monitoring in Obesity Without Diabetes: An Unnecessary Gadget or a Gateway to Precision Care? Diabetes, obesity & metabolism, 2026
- Clinical Outcomes of Multidisciplinary Remote Patient Monitoring for Patients With Poorly Controlled Type 2 Diabetes: Retrospective Cohort Study. JMIR diabetes, 2026
- Guiding Inpatient Glycemic Management with Continuous Glucose Monitoring. A Prospective Nonrandomized Comparative Cohort Study. Diabetes therapy : research, treatment and education of diabetes and related disorders, 2026
- Healthcare professionals' experience with early-stage (stage 1 and 2) type 1 diabetes and readiness for immunotherapies in adults: A UK-based survey. Diabetic medicine : a journal of the British Diabetic Association, 2026
Patients: Diabetes (adults)
| Place | Value | Year |
|---|---|---|
| World | 14.1 | 2022 |
| Australia | 8.1 | 2022 |
| Brazil | 12.9 | 2022 |
| Canada | 6.8 | 2022 |
| China | 11.2 | 2022 |
| Ecuador | 12.7 | 2022 |
| Egypt | 27.8 | 2022 |
| France | 2.7 | 2022 |
| Germany | 6.6 | 2022 |
| India | 22.6 | 2022 |
| Italy | 7.2 | 2022 |
| Japan | 6.4 | 2022 |
| Kenya | 5.6 | 2022 |
| Malaysia | 26.7 | 2022 |
| Mexico | 14.3 | 2022 |
| New Zealand | 9.0 | 2022 |
| Philippines | 13.2 | 2022 |
| Russia | 8.1 | 2022 |
| Saudi Arabia | 20.8 | 2022 |
| Singapore | 13.1 | 2022 |
| South Africa | 13.9 | 2022 |
| Spain | 3.6 | 2022 |
| Thailand | 12.3 | 2022 |
| UAE | 26.1 | 2022 |
| UK | 8.8 | 2022 |
| US | 12.5 | 2022 |
Key companies in Digital Diabetes Management
Medtronic
Abbott Laboratories
Dexcom, Inc.
Roche Diabetes Care
Ascensia Diabetes Care
Tandem Diabetes Care
Insulet Corporation
LifeScan, Inc.
Glooko, Inc.
Livongo Health (now part of Teladoc Health)
Quick answers
How much research is published on Digital Diabetes Management?
PubMed lists about 8,798 papers on the topic since 2021.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov. Research: PubMed (US National Library of Medicine). Patients: WHO Global Health Observatory. Fetched 10 Nov 2026. Trials and papers are found by search words, so counts are a guide.